Are we used the appropriate therapy regimens on advanced pancreatic cancer?

Abstract

Even through numerous combinations of chemotherapy regimens are used to treat on the advanced pancreatic cancer, APC; however, the survival rate (overall survival and progress free survival) and treatment-related toxicity remain challenge. Here we provided neutral and failed outcomes that treat the APC in clinical trials, this need us to think twice whether we were used the appropriate therapy regimens, to enlarge the survival rate and to reduce the treatment-related toxicity. Evidences of treatment on APC are need indeed to assistant our physician decision making correctly.